Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04469530
Title Sirolimus in Combination With Metronomic Chemotherapy in Children With High-Risk Solid Tumors (AflacST1903)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Emory University
Indications

sarcoma

Advanced Solid Tumor

Ewing sarcoma

rhabdomyosarcoma

osteosarcoma

rhabdoid cancer

Therapies

Celecoxib + Cyclophosphamide + Etoposide + Sirolimus

Age Groups: child | adult
Covered Countries USA

Facility Status City State Zip Country Details
Aflac Cancer & Blood Disorders Centers Recruiting Atlanta Georgia 30322 United States Details
Children's Healthcare of Atlanta Recruiting Atlanta Georgia 30322 United States Details
Washington University School of Medicine Recruiting Saint Louis Missouri 63110 United States Details
Children's Hospital of Pittsburgh of University of Pittsburgh Medical Center (UPMC) Recruiting Pittsburgh Pennsylvania 15224 United States Details
Texas Children's Cancer Center Not yet recruiting Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field